GBA1 and Parkinson disease: In this study, since the Gba1 mutations resulted in significantly increased GlcSph levels but did not result in pathological changes, even in aged mice, it appears that in the mouse, GluSph accumulation alone is not sufficient to generate PD phenotypes, including the loss of dopaminergic neurons and alpha-synuclein accumulation observed in patients with PD [32].